Search clinical trials for: paradoxical thromboembolism

Total 1127 results

Boehringer Ingelheim

Terminated

Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery

Venous Thromboembolism | Arthroplasty, Replacement

Austria
Inari Medical

Completed

FLowTriever for Acute Massive Pulmonary Embolism (FLAME) (FLAME)

PE - Pulmonary Embolism | PE - Pulmonary Thromboembolism

United States
Intermountain Health Care, Inc.

Terminated

Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis (ARM-DVT)

Deep Vein Thrombosis | Venous Thromboembolism | Deep Venous Thrombosis | Thrombus | Upper Extremity Deep Venous Thrombosis

United States
Scott C. Woller, MD
Bristol-Myers Squibb; University of Utah

Completed

Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome (ASTRO-APS)

Thrombosis | Antiphospholipid Syndrome

United States
University of Calgary
Canadian Institutes of Health Research (CIHR); Canadian Venous Thromboembolism...

Completed

Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity (PARTUM)

Aspirin | Venous Thromboembolism | Postpartum Period

Canada, France, Ireland, Netherlands
Methodist Health System

Enrolling by invitation

Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma

Thromboembolism, Venous

United States
Centre Hospitalier Universitaire de Nīmes

Completed

Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in Women (WAST-VTE)

Venous Thrombosis

France
Bayer

Completed

A Study to Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver Function

Atrial Fibrillation | Hepatic Impairment | Acute Myocardial Infarction | Prevention of Thromboembolic Events | Non-cardioembolic Ischemic Stroke

Germany
Boehringer Ingelheim

Completed

PraxbindTM India PMS Program

Thromboembolism

India
M.D. Anderson Cancer Center

Completed

Clearance Of Mucus In Stents (COMIS)

Myocardial Infarction | Pneumonia | Lung Neoplasms | Respiratory Failure | Unstable Angina | Cardiac Arrhythmia | Acute Coronary Syndromes | Thromboembolic Disease

United States
Momentum Data
Pfizer

Completed

The Incidence of Venous Thromboembolism in Atopic Dermatitis

Allergic Rhinitis | Deep Vein Thrombosis | Venous Thromboembolism | Atopic Dermatitis | Pulmonary Embolism | Food Allergy | Allergy to House Dust Mite | Allergy to Animal Dander | Cows Milk Allergy

United Kingdom
Assistance Publique Hopitaux De Marseille

Completed

Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole Genome

Venous Thromboembolism

France
Portola Pharmaceuticals

Completed

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study) (APEX)

Venous Thromboembolism (VTE)

Belgium, Israel, Italy, United States, France, Bulgaria, Australia, Germany, Russian Federation, Hungary, Singapore, Austria, Chile, Canada, United Kingdom, Czechia, Poland, Spain, Romania, Latvia, South Africa, Croatia, Serbia, Peru, U... and more
Central Hospital, Nancy, France
Ministry of Health, France; University Hospital of Saint-Etienne; Grand Est Region

Completed

Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 (COVI-DOSE)

Thrombosis | Deep Vein Thrombosis | COVID | Pulmonary Embolism

France
Portola Pharmaceuticals

Completed

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)

Thromboembolism

Canada
Assistance Publique Hopitaux De Marseille

Completed

Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis (MARTHARecidive)

Venous Thromboembolism (VTE)

France
Pfizer

Completed

Treatment Patterns and Bleeding Risk of Anticoagulants in Patients With Venous Thromboembolism in Korea

Venous Thromboembolism

Korea, Republic of
Brigham and Women's Hospital

Completed

Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism

United States
Brigham and Women's Hospital

Completed

Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism

United States
Brigham and Women's Hospital

Completed

Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism

United States
Brigham and Women's Hospital

Completed

Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism | Pulmonary Embolism | DVT

United States
Bayer

Completed

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis (CONVERT)

Hemodialysis | End-stage Renal Disease | Hemodiafiltration | Prevention of Thromboembolic Events

Spain, Greece, Belgium, Russian Federation, Netherlands, Turkey, Japan, Australia, Austria, Bulgaria, Italy, Ukraine, Czechia, Israel, United States, Hungary, Lithuania, Poland, Portugal
Yipeng Liu

Active, not recruiting

The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD

Diabetic Nephropathies | Thromboembolism | Glomerulonephritis, Membranous | Thrombelastography

China
Hospices Civils de Lyon

Completed

Complications Related to Vascular Access Devices in Home Parenteral Nutrition Patients (CRVADHPNP)

Vascular Access Complication

France
Centre Hospitalier Universitaire, Amiens

Completed

Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians (Observ-MTEV)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Survey | Anticoagulant

France
Medical University of Vienna

Completed

Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction Model

Venous Thromboembolism

Austria
Rijnstate Hospital

Completed

Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients (NADRO)

Critical Illness | Venous Thromboembolism | Therapeutic Drug Monitoring

Netherlands
Catalina Codreanu

Completed

Thrombosis in Patients With Multiple Myeloma in an University Medical Center (THRIMM)

Multiple Myeloma | Venous Thromboembolism | Arterial Thromboembolism

Netherlands
AHEPA University Hospital
Onassis Cardiac Surgery Centre; Attikon Hospital; MITERA Children's Hospital

Completed

Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study (PROTECT_AR)

Thromboembolism | Congenital Heart Disease | Atrial Arrhythmia | Anticoagulants Causing Adverse Effects in Therapeutic Use

Greece
Marc Blondon

Completed

Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study (PREFER-PP)

Pregnancy Related | Venous Thromboembolism

France, Switzerland
Centre Hospitalier Universitaire de Nīmes

Completed

Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism (CHIPS)

Venous Thromboembolism

France
University Hospital, Brest

Completed

Haemorrhages and Thromboembolic Venous Disease of the Postpartum (HEMOTHEPP)

Venous Thromboembolism | Postpartum Hemorrhage

France
Karolinska Institutet

Completed

Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients

Covid19 | Thromboembolism

Sweden
Gruppo Oncologico Italiano di Ricerca Clinica

Completed

Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy (EDOI)

Cancer | Thromboembolism

Italy
Sanofi

Active, not recruiting

A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

Venous Thromboembolism

United States
University Hospital, Geneva

Completed

Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial (PP-HEP)

Venous Thromboembolism

Switzerland
Sanofi

Active, not recruiting

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

Venous Thromboembolism

United States
University of Turku

Completed

Atrial Fibrillation as a Cause of Stroke and Intracranial Hemorrhage Study (The FibStroke Study) (FibStroke)

Stroke | Atrial Fibrillation | Transient Ischemic Attacks | Intracranial Hemorrhage

Finland
University of Utah

Completed

Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
CHAD

Terminated

The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register) (START-Portugal)

Atrial Fibrillation | Venous Thromboembolism | Heart Valve Diseases or Prosthesis

Portugal
University of Calgary

Completed

Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke (AcT)

Stroke, Acute | Thromboses, Intracranial

Canada
Tampere University Hospital
Heart Hospital, Tampere University Hospital

Completed

: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

Venous Thromboembolism | Pulmonary Embolism | Thromboprophylaxis

Finland
Yang I. Pachankis

Active, not recruiting

COVID-19 Vaccination Detoxification in LDL-C

COVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated Stroke

China
McMaster University
St. Joseph's Healthcare Hamilton; Hamilton Health Sciences Corporation

Completed

Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry (PAUSE-ER)

Atrial Fibrillation | Venous Thromboembolism | Arterial Vascular Disease

Canada
Denver Health and Hospital Authority

Terminated

STAT-STatin and Aspirin in Trauma (STAT)

Wounds and Injuries | Venous Thromboembolism

United States
Sinomed Neurovita Technology Inc.

Terminated

Safety and Efficacy of Intracranial Thrombus Aspiration Catheter in the Treatment of Acute Large-vessel Occlusive Stroke

Acute Ischemic Stroke | Aspiration | Large-vessel Occlusion

China
The University of Texas Medical Branch, Galveston

Withdrawn

The Correlation of a D-dimer Testing Protocol With Venous Thromboembolism in Surgical Colorectal Patients

Colorectal Cancer | Crohn Disease | Deep Vein Thrombosis | Ulcerative Colitis | Diverticular Diseases | Venous Thromboses
Daiichi Sankyo, Inc.

Completed

Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism

Pulmonary Embolism | Thrombotic Disease

Netherlands, Spain, United States, France, Austria, Belgium, Germany, Italy
Montefiore Medical Center
The Plastic Surgery Foundation

Completed

Use of Tranexamic Acid in Reduction Mammoplasty (TREX-ARM)

Venous Thromboembolism | Hematoma Postoperative

United States
Nottingham University Hospitals NHS Trust

Active, not recruiting

Sonoclot to Evaluate Thrombotic Risk in Proteinuric Pregnancy

Chronic Kidney Diseases | Pregnancy Complications | Venous Thromboembolism | Proteinuria in Pregnancy

United Kingdom

Search clinical trials for: paradoxical thromboembolism

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations